|Articles|July 1, 2001

July 2001
Volume 7
Issue 7

Physician Characteristics and the Initiation of Beta-Adrenergic Blocking Agent Therapy After Acute Myocardial Infarction in a Managed Care Population

Author(s)S. Nicole Fehrenbach, MPP, Daniel S. Budnitz, MD, MPH, Julie A. Gazmararian, MPH, PhD

Download PDF: Physician Characteristics and the Initiation of Beta-Adrenergic Blocking Agent Therapy After Acute Myocardial Infarction in a Managed Care Population

Articles in this issue

about 25 years ago

Article

Electronic Prescribing in Ambulatory Practice: Promises, Pitfalls, and Potential Solutions

about 25 years ago

Article

Another Theory About Healthcare Expenditures and Inflation Refuted by the Facts

about 25 years ago

Article

Decomposing Pharmaceutical Cost Growth in Different Types of Health Plans

about 25 years ago

Article

Economic Evaluation of Lamivudine Compared with Interferon-Alpha in the Treatment of Chronic Hepatitis B in the United States

about 25 years ago

Article

Promoting Smoking Abstinence in Pregnant and Postpartum Patients: A Comparison of Two Approaches

about 25 years ago

Article

Primary Care Physician Job Satisfaction and Turnover

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Physician Characteristics and the Initiation of Beta-Adrenergic Blocking Agent Therapy After Acute Myocardial Infarction in a Managed Care Population

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access